Kazuomi Kario

Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (33)

Hypertension remains a leading global cause of cardiovascular morbidity and mortality, yet blood pressure control rates remain suboptimal despite advances in antihypertensive therapy. Multiple barriers—including cost, side effects, therapeutic complexity, and physician inertia—impede effective management, particularly in aging populations and low-resource settings. This review evaluates the therapeutic role of doxazosin, particularly in its extended-release gastrointestinal therapeutic system formulation, as a potential adjunct in contemporary hypertension treatment, including resistant hypertension.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

The second Asia Renal Denervation Consortium consensus conference shared information and developed updated recommendations for renal denervation (RDN). Current evidence confirms that RDN significantly reduces blood pressure across all metrics (office, home, and ambulatory) throughout 24 hours. Modern RDN approaches target the distal main renal artery and branches where nerves more closely approximate the vessel wall. Understanding renal artery anatomy is crucial; the main renal artery typically divides into anterior and posterior divisions as first-order branches, which further subdivide into second-order segmental arterial branches. Renal artery electrical stimulation shows promise as a procedural end point, with blood pressure response attenuation after successful RDN suggesting adequate denervation, though the optimal procedural end point remains to be established. The indication for RDN is resistant or uncontrolled hypertension, with high office, home, or 24-hour ambulatory blood pressure readings despite appropriate lifestyle modification and antihypertensive drug therapy. Preprocedure assessment includes comprehensive screening for secondary causes and detailed renal artery imaging. Checklists for preprocedure and postprocedure assessment are provided. Nocturnal hypertension and morning hypertension, which are common in Asia, are more closely associated with cardiovascular risk than daytime hypertension and are more difficult to control with current guideline-driven medication. Based on these Asian characteristics and RDN’s long-term durability, RDN should be considered an effective option for facilitating optimal 24-hour blood pressure control. Future research through real-world data collection will help determine ethnic differences in RDN response between Asians and Westerners and identify optimal candidates. In addition, studies are needed to evaluate RDN’s ability to prevent organ damage and cardiovascular events.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (36)

Hiroshi Itoh

Keio University School of Medicine

JAPAN
View details

James Sheppard

University of Oxford

UNITED KINGDOM
View details

Sadayoshi Ito

Professor

Tohoku University

JAPAN
View details

Karl Fengler

-

GERMANY
View details

Hideo Fujita

professor

Jichi Medical University Saitama Medical Center

JAPAN
View details

Felix Mahfoud

Director

University Hospital Basel

SWITZERLAND
View details

Miguel Camafort

Associate Professor

University of Barcelona

SPAIN
View details

Hae-Young Lee

Seoul National University College of Medicine

SOUTH KOREA
View details

Lucas Lauder

University Hospital Basel

SWITZERLAND
View details

Yoshihiro Miyamoto

Director General

National Cerebral and Cardiovascular Center

JAPAN
View details

Ingrid Hopper

Monash University Malaysia.

AUSTRALIA
View details

Tomoyuki Tanigawa

St. Luke's International University

JAPAN
View details

Tetsuya Matoba

Associate Professor

Kyushu University Hospital

JAPAN
View details

Taishi Nakamura

Associate Professor

Kumamoto University Hospital

JAPAN
View details

Wataru Umishio

Assistant Professor

Tokyo Institute of Technology

JAPAN
View details

Yook-Chin Chia

Research Professor and Head of Ageing, Health and Wellbeing Research Centre (CARE)

Sunway University

MALAYSIA
View details

Richard J. McManus

Dean

University of Oxford

UNITED KINGDOM
View details

Masaharu Nakayama

Professor

Tohoku University

JAPAN
View details

Kenichi Tsujita

Professor of Medicine

Kumamoto University

JAPAN
View details

Yoshihisa Fujino

Professor

University of Occupational and Environmental Health Japan

JAPAN
View details

Satoshi Hoshide

-

JAPAN
View details

Satoshi Yasuda

Professor and chairmam

Tohoku University graduate school of medicine

JAPAN
View details

Stuart Pocock

Professor of Medical Statistics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Faisal Sharif

University of Galway

IRELAND
View details

Kenichiro Otsuka

Associate Professor

Osaka University Graduate School of Medicine

JAPAN
View details

Masayuki Takamura

-

JAPAN
View details

keisuke narita

Jichi Medical University

JAPAN
View details

Shuntaro Sato

Nagasaki University

JAPAN
View details

Konstantinos Toutouzas

-

GREECE
View details

Akihiro Nomura

Assistant Professor

Kanazawa University

JAPAN
View details

Atsushi Shibata

Osaka University

JAPAN
View details

Daiju Fukuda

-

JAPAN
View details

Asahiro Ito

Osaka University Graduate School of Medicine

JAPAN
View details

Koichi Node

教授

Saga University

JAPAN
View details

Keith C. Ferdinand

-

UNITED STATES
View details

Jun Takahashi

Associate Professor

Tohoku University Hospital

JAPAN
View details